Phytonutrients and Neurological Disorders: Therapeutic and Toxicological Aspects provides and assesses the latest research and developments surrounding the use of phytonutrients for the treatment of neurological disorders. The volume analyzes advances in phytonutrient isolation, characterization and therapeutic applications, giving particular emphasis to mechanisms and safety profiles. The book takes toxicological considerations into account, including adverse drug reactions, toxicokinetics and toxicodynamics. Sections cover bioactive compound classes and biosynthesis pathways, general considerations, including quality control, standardization, and technology, and toxicology. This title is a comprehensive work on the latest research in phytonutrients and neurological disorders that will be useful to researchers and medical practitioners.

• Presents a comprehensive resource on phytonutrients and their relationship to neurological disorders
• Analyzes the isolation, characterization and mechanisms of phytonutrients in neurology
• Focuses on various signaling pathways followed by phytonutrients in neuroprotection
• Gives the latest thinking on quality control parameters and specifications for phytonutrient study
• Considers the toxicology of phytonutrients, including adverse drug reactions, toxicokinetics and toxicodynamics

Part A, Section 1: Bioactive compound classes and biosynthesis pathway1. Current therapies for neurological disorders and their limitations2. Biosynthesis of phytonutrients3. Neuroprotective effects of flavonoids4. Neuroprotective effects of glycosides5. Neuroprotective effects of terpenoids6. Neuroprotective effects of alkaloids7. Neuroprotective effects of saponins8. Neuroprotective effects of steroids9. Neuroprotective effects of essential oils10. Neuroprotective effects of phytonutrients at gene levelsPart A Section 2: General considerations11. Latest development in quality control parameters/specification in phytonutrients studies12. Phytonutrients standardization for effective therapeutic outcomes13. Phytonutrients and technological development in formulationsPart B Sections: Toxicological considerations in phytonutrientsa. Adverse drug reactionsb. Toxicokineticsc. Toxicodynamics